Skip to content

Achieve Life Sciences ACHV Share-based compensation expense related to employee stock plans

Share-based compensation expense related to employee stock plans at other companies

General Motors logo
General MotorsGM
-$188M-1,989%
Devon Energy logo
Devon EnergyDVN
$22M-26.7%
T-Mobile US logo
T-Mobile USTMUS
$226M+27.7%
PayPal Holdings, Inc. logo
PayPal Holdings, Inc.PYPL
$292M+2.5%
Cadence Design Systems logo
Cadence Design SystemsCDNS
$138.18M+28.4%
Clear Channel Outdoor Holdings, Inc. logo
Clear Channel Outdoor Holdings, Inc.CCO
-6.8%-15.0pp

Other financials

Income statement

See full
Net income-$10.2M+20.7%
EPS (diluted)-$0.19+48.6%

Balance sheet

See full
Cash & equivalents$28.1M+116%
Total debt$5.6M+332%
Total equity$10.7M+3.9%
Total assets$33.1M+21.0%

Cash flow

See full
Operating cash flow-$6.9M+37.5%
CapEx$750.0
Free cash flow-$12.4M

Valuation

See full
Market cap$585.16M+404%
Enterprise value$562.71M+439%

Returns & leverage

See full
Return on equity-496.1%-906pp
Debt / equity0.5×+0.4×
Current ratio2.6×-0.9×

Where this comes from

Reported directly by Achieve Life Sciences in its filing.

Tagged under the XBRL concept us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue.

The official record: Achieve Life Sciences’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Achieve Life Sciences's share-based compensation expense related to employee stock plans.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Achieve Life Sciences's share-based compensation expense related to employee stock plans?
Achieve Life Sciences (ACHV) reported share-based compensation expense related to employee stock plans of -$685K in Q1 2026.
How has Achieve Life Sciences's share-based compensation expense related to employee stock plans changed year-over-year?
Achieve Life Sciences's share-based compensation expense related to employee stock plans decreased by 130.7% year-over-year, from $2.23M to -$685K.
What is the long-term trend for Achieve Life Sciences's share-based compensation expense related to employee stock plans?
Over 4 years (2021 to 2025), Achieve Life Sciences's share-based compensation expense related to employee stock plans has grown at a 41.5% compound annual growth rate (CAGR), from $2.19M to $8.76M.